16-21250596-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_145865.3(ANKS4B):c.1030G>A(p.Asp344Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,613,998 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145865.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANKS4B | NM_145865.3 | c.1030G>A | p.Asp344Asn | missense_variant | 2/2 | ENST00000311620.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANKS4B | ENST00000311620.7 | c.1030G>A | p.Asp344Asn | missense_variant | 2/2 | 1 | NM_145865.3 | P1 | |
CRYM | ENST00000574448.5 | c.*521-6528C>T | intron_variant, NMD_transcript_variant | 1 | |||||
CRYM | ENST00000570401.5 | c.265-6528C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152112Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 249058Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135108
GnomAD4 exome AF: 0.0000308 AC: 45AN: 1461886Hom.: 1 Cov.: 31 AF XY: 0.0000330 AC XY: 24AN XY: 727244
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152112Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 18, 2023 | The c.1030G>A (p.D344N) alteration is located in exon 2 (coding exon 2) of the ANKS4B gene. This alteration results from a G to A substitution at nucleotide position 1030, causing the aspartic acid (D) at amino acid position 344 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at